Experience

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25 billion aggregate principal amount of notes by Medtronic Global…

 Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross proceeds of $204 million. ADC Therapeutics is listed on the New York…

Davis Polk advised Kingsoft Cloud Holdings Limited and certain selling shareholders on its approximately $509 million SEC-registered follow-on public offering of 16,421,576 American…

Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong Stock Exchange. Zai Lab is the first company listed under both…

Davis Polk advised NatWest Group plc in connection with its cash tender offer for any and all of certain series of its outstanding bank capital securities.NatWest Group is the holding…

Davis Polk advised the joint bookrunners and representatives of the several underwriters in connection with concurrent SEC-registered offerings by (1) B.A.T Capital Corporation of $1.75…

Davis Polk advised Ming Yuan Cloud Group Holdings Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in…

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. in connection with its reopening of its July 2020 SEC-registered takedown offering of senior TLAC notes. The reopening consisted of …

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. on its $850 million SEC-registered takedown offering of 2.142% subordinated notes due 2030. The subordinated notes are expected to…

Davis Polk advised JPMorgan Chase & Co. in connection with the update of a Euro medium-term note program under which notes may be issued by JPMorgan Chase & Co. and JPMorgan Chase…